Article Information
History
- November 9, 2021.
Article Versions
- Version 1 (October 20, 2021 - 13:56).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- 1Functional Genomics and Bioinformatics Group, Department of Biochemistry and Molecular Biology, Federal University of Ceará, Fortaleza, Brazil
- 2Plant Molecular and Cellular Biotechnology / Industrial Biotechnology and Bioproducts. Department of Life and Agricultural Sciences. Universidad de las Fuerzas Armadas-ESPE, Ecuador
- 3Non-Institutional Competence Focus (NICFocus) ‘Functional Cell Reprogramming and Organism Plasticity’ (FunCROP), coordinated from Foros de Vale de Figueira, Alentejo, Portugal
- ↵*Corresponding authors: Birgit Arnholdt-Schmitt
, Non-Institutional Competence Focus (NICFocus) ‘Functional Cell Reprogramming and Organism Plasticity’ (FunCROP), coordinated from Foros de Vale de Figueira, Alentejo, Portugal, Email: biarnaflora{at}gmail.com, José Hélio Costa
, Functional Genomics and Bioinformatics Group, Department of Biochemistry and Molecular Biology, Federal University of Ceará, Fortaleza, Brazil, Email: helio.costa{at}ufc.br
Posted November 09, 2021.
Major complex trait for early de novo programming ‘CoV-MAC-TED’ detected in human nasal epithelial cells infected by two SARS-CoV-2 variants is promising for designing therapeutic strategies
